Leonid Timashev's Stock Ratings

RBC Capital Analyst

Leonid Timashev is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

-4.75%

Smart Score

Overall Average Return Percentile

28th

Number of Ratings

		Buy Now							Get Alert
05/14/2024	LEGN	Buy Now	Legend Biotech	$39.76	116.3%	$85 → $86	Maintains	Outperform	Get Alert
04/22/2024	EWTX	Buy Now	Edgewise Therapeutics	$17.13	86.81%	$28 → $32	Maintains	Outperform	Get Alert
04/09/2024	BHVN	Buy Now	Biohaven	$35.10	73.79%	→ $61	Reiterates	Outperform → Outperform	Get Alert
Make more informed trades with Benzinga Pro You're only getting a peek at the whole story!
03/26/2024	AXSM	Buy Now	Axsome Therapeutics	$73.43	74.32%	$123 → $128	Maintains	Outperform	Get Alert
03/22/2024	PYXS	Buy Now	Pyxis Oncology	$3.80	84.21%	→ $7	Reiterates	Outperform → Outperform	Get Alert
03/20/2024	DSGN	Buy Now	Design Therapeutics	$4.06	-1.48%	→ $4	Reiterates	Sector Perform → Sector Perform	Get Alert
03/12/2024	LEGN	Buy Now	Legend Biotech	$39.76	113.78%	→ $85	Reiterates	Outperform → Outperform	Get Alert
03/12/2024	EWTX	Buy Now	Edgewise Therapeutics	$17.13	63.46%	→ $28	Reiterates	Outperform → Outperform	Get Alert
03/08/2024	LEGN	Buy Now	Legend Biotech	$39.76	113.78%	→ $85	Reiterates	Outperform → Outperform	Get Alert
03/07/2024	LEGN	Buy Now	Legend Biotech	$39.76	113.78%	→ $85	Reiterates	Outperform → Outperform	Get Alert
03/01/2024	BHVN	Buy Now	Biohaven	$35.10	73.79%	$62 → $61	Maintains	Outperform	Get Alert
02/29/2024	NAMS	Buy Now	NewAmsterdam Pharma	$18.75	65.33%	$25 → $31	Maintains	Outperform	Get Alert
02/21/2024	AXSM	Buy Now	Axsome Therapeutics	$73.43	67.51%	$126 → $123	Maintains	Outperform	Get Alert
02/16/2024	BHVN	Buy Now	Biohaven	$35.10	76.64%	→ $62	Initiates	→ Outperform	Get Alert
01/25/2024	AXSM	Buy Now	Axsome Therapeutics	$73.43	71.59%	→ $126	Initiates	→ Outperform	Get Alert
11/14/2023	DSGN	Buy Now	Design Therapeutics	$4.06	-1.48%	$7 → $4	Maintains	Sector Perform	Get Alert
10/30/2023	NAMS	Buy Now	NewAmsterdam Pharma	$18.75	33.33%	→ $25	Initiates	→ Outperform	Get Alert
09/05/2023	PYXS	Buy Now	Pyxis Oncology	$3.80	84.21%	→ $7	Initiates	→ Outperform	Get Alert
08/15/2023	DSGN	Buy Now	Design Therapeutics	$4.06	72.41%	$23 → $7	Downgrade	Outperform → Sector Perform	Get Alert
06/28/2023	EWTX	Buy Now	Edgewise Therapeutics	$17.13	63.46%	→ $28	Reiterates	Outperform → Outperform	Get Alert
06/16/2023	LEGN	Buy Now	Legend Biotech	$39.76	108.75%	→ $83	Reiterates	Outperform → Outperform	Get Alert
05/19/2023	LEGN	Buy Now	Legend Biotech	$39.76	108.75%	$74 → $83	Maintains	Outperform	Get Alert
05/10/2023	DSGN	Buy Now	Design Therapeutics	$4.06	466.5%	$24 → $23	Maintains	Outperform	Get Alert
03/24/2023	LEGN	Buy Now	Legend Biotech	$39.76	83.6%	→ $73	Initiates	→ Outperform	Get Alert
03/15/2023	DSGN	Buy Now	Design Therapeutics	$4.06	491.13%	→ $24	Reiterates	→ Outperform	Get Alert
12/08/2022	DSGN	Buy Now	Design Therapeutics	$4.06	491.13%	$29 → $24	Maintains	Outperform	Get Alert
11/04/2022	EWTX	Buy Now	Edgewise Therapeutics	$17.13	69.29%	$31 → $29	Maintains	Outperform	Get Alert
10/18/2022	NBSE	Buy Now	NeuBase Therapeutics	—	—	$240 → $20	Downgrade	Outperform → Sector Perform	Get Alert
05/02/2022	DSGN	Buy Now	Design Therapeutics	$4.06	638.92%	→ $30	Initiates	→ Outperform	Get Alert
04/13/2022	EWTX	Buy Now	Edgewise Therapeutics	$17.13	80.97%	→ $31	Initiates	→ Outperform	Get Alert